Seeing Is Believing
Currently out of the existing stock ratings of Yaron Werber, 67 are a BUY (71.28%), 26 are a HOLD (27.66%), 1 are a SELL (1.06%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 64.09% that have a potential upside of 26.97% achieved within 373 days. Previously, Yaron Werber worked at COWEN.
Yaron Werber’s has documented 178 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 15-Nov-2024.
Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$256
$-7.38 (-2.80%)
$335
14 days ago
(10-Dec-2024)
7/9 (77.78%)
$-19.95 (-7.23%)
593
Buy
$330
$66.62 (25.29%)
$362
27 days ago
(27-Nov-2024)
10/13 (76.92%)
$50.09 (17.90%)
72
Buy
$380
$116.62 (44.28%)
$345
1 months 12 days ago
(12-Nov-2024)
22/24 (91.67%)
$59.89 (18.71%)
644
Hold
$326
$62.62 (23.78%)
$307
1 months 23 days ago
(31-Oct-2024)
10/11 (90.91%)
$5.84 (1.82%)
83
Buy
$333
$69.62 (26.43%)
$320
2 months 10 days ago
(14-Oct-2024)
25/26 (96.15%)
$8.38 (2.58%)
703
Which stock is Yaron Werber is most bullish on?
Which stock is Yaron Werber is most reserved on?
What Year was the first public recommendation made by Yaron Werber?